← Open Payments lookup

ELIZABETH BAILEY: Open Payments

NPI 1215004809 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 40 payments from 13 companies in 2025. Trend: 2023 $2,484 · 2024 $17,194 · 2025 $1,519

Food & beverage: $888Consulting: $550Travel & lodging: $68Education: $12
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$572
ABBVIE INC.10$252
Madrigal Pharmaceuticals8$236
Boston Scientific Corporation2$115
Takeda Pharmaceuticals U.S.A., Inc.3$74
Janssen Biotech, Inc.2$49
Lilly USA, LLC2$42
Regeneron Healthcare Solutions, Inc.2$41
Gilead Sciences, Inc.2$33
Novo Nordisk Inc2$33

Products named: XIFAXAN, REZDIFFRA, General - Therapies, ENTYVIO, LINZESS, DUPIXENT, RINVOQ, TREMFYA.

Industry payments across ME — which companies pay providers there.